05/12/2022
The FDA has approved an extended-release version of the GLP-1 drug exenatide for older children and teenagers with …
A new report states diabetes teams have learnt how to adapt to the ‘new normal’ amid Covid-19 but …
Type 2 diabetes European Commission has granted marketing authorization in Europe. For Sanofi’s Suliqua, a once-daily injection for …